Cutting Edge (Surgical Devices) logo

Cutting Edge (Surgical Devices)

Current Valuation
$17.1M
As of July 17, 2024
Total Funding Raised
$13.7M
Last Round
Later Stage VC

$8.3M

Last Funding
Jul 2024

Funding date

Capital Efficiency
1.25x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Cutting Edge (Surgical Devices) is currently valued at $17.1M as of July 17, 2024. The company has raised a total of $13.7M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.25x, Cutting Edge (Surgical Devices) has achieved a valuation that is 1.25 times the total capital raised. This metric indicates room for improvement in capital deployment.

Investment Perspective

Cutting Edge (Surgical Devices)'s valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Cutting Edge (Surgical Devices) Valuation Updates

Get notified when Cutting Edge (Surgical Devices) raises new funding or valuation changes

What is Cutting Edge (Surgical Devices) Worth in 2025?

As of 2025, Cutting Edge (Surgical Devices) is valued at $17.1M, based on the company's Later Stage VC funding round in July 17, 2024. This valuation positions Cutting Edge (Surgical Devices) as one of the leading private companies in the sector.

Cutting Edge (Surgical Devices) Valuation History

Cutting Edge (Surgical Devices)'s funding history demonstrates steady growth and investor confidence.

How Cutting Edge (Surgical Devices) Valuation is Determined

Private company valuations like Cutting Edge (Surgical Devices)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Cutting Edge (Surgical Devices) Valuation FAQs

Is Cutting Edge (Surgical Devices) profitable?

Cutting Edge (Surgical Devices) has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Cutting Edge (Surgical Devices)'s valuation compare to competitors?

Cutting Edge (Surgical Devices) is valued at $17.1M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Cutting Edge (Surgical Devices) IPO?

Cutting Edge (Surgical Devices) has not announced plans for an initial public offering. Until an IPO, investors can access Cutting Edge (Surgical Devices) shares through secondary market platforms.